Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Raphael Pharma cannabinoid-based formula (cancer-related symptoms)
- Development stage
- Preclinical
- Lead developer
- Raphael Pharma
- Modality
- Small Molecules
01
Overview
Raphael Pharma is developing an unnamed, preclinical cannabinoid-based formulation for the palliative treatment of various cancer-related symptoms. This small molecule approach utilizes proprietary cannabis strains to target cannabinoid receptors, aiming to alleviate cachexia (appetite and weight loss), fatigue, anemia, pain, and depression. The program is being conducted in collaboration with the Rambam Health Care Campus and Schneider Children's Medical Center of Israel, focusing on both adult and pediatric oncology patients. The mechanism of action involves cannabinoid receptor-mediated symptomatic treatment to address multiple conditions associated with cancer and its treatment.
- Other names
- Cannabinoid-based formulaProprietary cannabis strains (Raphael Pharma)
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Raphael Pharma cannabinoid-based formula (cancer-related symptoms).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Raphael Pharma cannabinoid-based formula (cancer-related symptoms).